BioSpace News Archive

Journey Biosciences, Inc., a biotechnology company with an innovative proactive diagnostic screening technology for high risk kidney complications associated with Diabetes, today announced their company launch, and introduction of their flagship product, NaviDKD.

Merck KGaA, Darmstadt, Germany, a leading science and technology company, today announced a mutual decision with GSK to terminate their agreement on bintrafusp alfa, effective September 30, 2021.

GigaGen Inc., a biotechnology company advancing transformative antibody drugs for infectious diseases, transplant rejection and checkpoint resistant cancers, and a subsidiary of Grifols, announced today that it has signed a license agreement with Dutch biotech ProteoNic B.V. for the use of its premium 2G UnicTM technology platform to enable high-yield production of GigaGen’s mono- and polyclonal antibody drug candidates.

Lineage Cell Therapeutics, Inc. (NYSE American and TASE: LCTX), a clinical-stage biotechnology company developing allogeneic cell therapies for unmet medical needs, reported today that updated interim results from a Phase 1/2a clinical study of its lead product candidate, OpRegen®,

At the 2021 AACC Annual Scientific Meeting & Clinical Lab Expo, September 26-30, AACC was proud to welcome thousands of laboratory medicine professionals, all of whom have been on the frontlines of COVID-19 testing.

Biologica Technologies, developers and marketers of ProteiOS® growth factor and OsseoGEN® cellular bone matrix, announced today the podium presentation, ‘Retrospective assessment of radiographic outcomes after implantation of a novel allograft growth factor combined with scaffold in patients undergoing XLIF, LLIF, and TLIF procedures’

X-Nav Technologies is proud to announce that over 150,000 dental implants have been surgically placed using X-Guide® Dynamic 3D Navigation – a system designed to assist dental surgeons in achieving more accurate and less invasive dental implant results than freehand surgery.

The American Diabetes Association® announced that applications for grants are being accepted for two new research initiatives, leveraging nutrition and lifestyle for diabetes prevention, and precision medicine to improve the management of diabetes.

CareDx, Inc. announced a publication in Kidney360 of a multicenter study that demonstrates the clinical performance of AlloSure and AlloMap to inform biopsy and treatment decisions following kidney transplantation.

Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical company developing potential new medicines for patients with pediatric cancers, solid tumors, and other cancers, and Nationwide Children’s Hospital disclosed today that an abstract has been accepted by the American Association for Cancer Research (AACR) for poster presentation at the 2021 AACR-NCI-EORTC Virtual International Conference.